Intranasal naloxone for the reversal of opioid overdose: A double-blinded, double-dummy controlled non-inferiority trial in Sydney’s Medically Supervised Injecting Centre

Name & Contact Details Role Research Program Location
Placeholder image

Professor Paul Dietze
Tel: 61 (0)409530027
paul.dietze@curtin.edu.au
View profile

Chief Investigator

Harm reduction policy and strategies

Melbourne

Placeholder image

Professor Simon Lenton
Tel: 61 (0)8 9266 1603
s.lenton@curtin.edu.au
View profile

Chief Investigator

Harm reduction policy and strategies

Perth

  • Chief Investigator: Marianne Jauncey, Uniting Medically Supervised Injecting Centre
  • Chief Investigator: John Strang, King's College London
  • Chief Investigator: Debra Kerr, Deakin University
  • Chief Investigator: Allison Salmon, Cancer Council NSW
  • Chief Investigator: Paul Agius, Burnet Institute

This project aligns with the following Sustainable Development Goals and Targets: